Neuro-Oncology Pediatrics Launches to Advance Global Research and Care for Children and Young Adults with Brain Tumors
Neuro-Oncology Pediatrics is now live! This new open-access, interdisciplinary journal is dedicated to advancing the field of pediatric and adolescent/young adult (AYA) neuro-oncology. It publishes high-quality basic, translational, and clinical research spanning the full spectrum of brain, spine, and peripheral nerve tumors affecting children and AYAs, including studies on late effects, survivorship, and quality of life.
The journal’s scope reflects the breadth and complexity of the field, welcoming work that addresses tumor biology, innovative diagnostics, precision medicine, novel therapeutics, supportive care, neuroimaging, epidemiology, clinical trials, and health equity. Neuro-Oncology Pediatrics aims to be a global forum where multidisciplinary teams can share discoveries that directly improve patient outcomes.
"I am thrilled to see our inaugural content now available online," said Editor-in-Chief Sabine Mueller, MD, PhD, MAS. "This milestone marks the beginning of our mission to advance education, foster innovation, and equip the clinical and research communities with the knowledge they need to improve outcomes for pediatric and AYA patients worldwide."
The fourth title in the Neuro-Oncology family of journals, Neuro-Oncology Pediatrics, is published by Oxford University Press and is co-owned by the European Association of Neuro-Oncology (EANO) and the Society for Neuro-Oncology (SNO). The editorial leadership team includes representatives from the three charter members of the World Federation of Neuro-Oncology Societies – the Asian Society for Neuro-Oncology (ASNO), EANO, and SNO – ensuring a truly international perspective.
"This new journal represents a major step forward in how we share and disseminate advances in pediatric neuro-oncology," said Michael Platten, MD, President of EANO. "By bringing together global expertise, we can accelerate progress against these devastating diseases."
Daphne Haas-Kogan, MD, President of SNO, added: "Our vision is to provide a dedicated platform for the pediatric neuro-oncology community—one that fosters collaboration across continents and disciplines, and ultimately drives better care and cures for young patients."
The launch of Neuro-Oncology Pediatrics was made possible in part through a generous grant from the Pediatric Brain Tumor Foundation. "We are deeply grateful for the Foundation’s support, which has helped make this important new resource a reality," said Dr. Haas-Kogan. "Their commitment to advancing research and improving the lives of children with brain tumors is inspiring."
With its inaugural content now online, Neuro-Oncology Pediatrics begins its journey to inform, inspire, and support the global community working to improve care for children and AYAs affected by brain and nervous system tumors.
For more information and to access the journal, click here.
Professor Wolfgang Wick Appointed Editor-in-Chief of Neuro-Oncology Advances
The European Association of Neuro-Oncology (EANO) and the Society for Neuro-Oncology (SNO) are delighted to jointly announce the appointment of Professor Wolfgang Wick, MD, as the new Editor-in-Chief of Neuro-Oncology Advances.
Launched in 2019 as a joint initiative between EANO and SNO, Neuro-Oncology Advances has established itself as a key open-access journal in our field. With an Impact Factor of 4.1 in 2024 and a growing global readership, the journal continues to thrive as a platform for high-quality basic, translational, and clinical research. We warmly thank Professor Gelareh Zadeh for her exceptional leadership over the past seven years. Under her guidance, the journal has seen impressive growth in scope, visibility, and impact.
Professor Wick’s appointment marks a major milestone for Neuro-Oncology Advances. With his deep editorial experience, global reputation, and collaborative spirit, we are confident he will further elevate the journal’s scientific impact, global reach, and innovative direction. We look forward to working with him in continuing to advance the visibility, excellence, and influence of Neuro-Oncology Advances as a cornerstone publication in our field.
We congratulate Professor Wick on his appointment and express our full confidence and enthusiasm as he takes on this important leadership role.
On behalf of EANO and SNO,
Michael Platten, President of EANO
Daphne Haas-Kogan, President of SNO
Don't Forget to Renew your EANO Membership!
If you have not done so yet, and would like to renew your EANO membership for 2025, please log in via EANO’s member portal to update your data and renew your membership. Please note that membership runs on the calendar year, January 1st till December 31st, regardless of the date of renewal.
Membership benefits of the European Association of Neuro-Oncology:
- free access to Neuro-Oncology, Neuro-Oncology Practice, Neuro-Oncology Advances
- networking, establish collaborations, exchange with experts, share knowledge, get inspired by others
- reduced registration fees for EANO Meetings
- reduced registration for teaching events
- support your professional career via educational events, scholarships and mentorships
- being part of a broader European Neuro-Oncology community
EANO Diversity Statement
The Disparity Committe has been working on creating the EANO Diversity Statement which lines out the aim of EANO to create a diverse and equal community. Read more here...